Apixaban + Placebo
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Venous Thrombosis
Conditions
Venous Thrombosis
Trial Timeline
May 1, 2008 → Aug 1, 2012
NCT ID
NCT00633893About Apixaban + Placebo
Apixaban + Placebo is a phase 3 stage product being developed by Pfizer for Venous Thrombosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00633893. Target conditions include Venous Thrombosis.
What happened to similar drugs?
6 of 20 similar drugs in Venous Thrombosis were approved
Approved (6) Terminated (2) Active (13)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00831441 | Phase 3 | Terminated |
| NCT00633893 | Phase 3 | Completed |
Competing Products
20 competing products in Venous Thrombosis